Skip to content

Clinical trials

Phase 2 RNA Virus Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: RNA Virus Infections Phase: Phase 2 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20141
20151
20162
20172
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medicago3
Gilead Sciences2
Biomedical Advanced Research and Development Authority1
Myrexis Inc.1
National Institute of Allergy and Infectious Diseases (NIAID)1
Seqirus1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
RNA Virus Infections10
Virus Diseases9
Infections7
Respiratory Tract Diseases6
Respiratory Tract Infections6
Influenza, Human5
Orthomyxoviridae Infections5
Flaviviridae Infections2
Hepatitis C2
Influenza in Birds2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.